The effects of Remifemin® on subjective symptoms of menopause

Gabor Vermes, F. Bánhidy, N. Ács, Julianna Csikós

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The authors studied the changes in subjective symptoms of menopause in 2016 Hungarian women who had been treated with an isopropanol extract of Cimicifuga racemosa (black cohosh). The inclusion criteria were age (40-65 y). Kupperman index (20), and refusal or contraindication for estrogen therapy. The severity of the symptoms was evaluated at the start of the study and at the end of 4, 8, and 12 weeks of treatment. The average decrease in Kupperman index after 12 weeks of therapy was 17.64 points (P

Original languageEnglish
Pages (from-to)148-154
Number of pages7
JournalAdvances in Therapy
Volume22
Issue number2
Publication statusPublished - Mar 2005

Fingerprint

Menopause
Cimicifuga
2-Propanol
Estrogens
Therapeutics
Remifemin

Keywords

  • Black cohosh
  • Cimicifuga racemosa
  • Menopause
  • Phyto-SERM
  • Remifemin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The effects of Remifemin® on subjective symptoms of menopause. / Vermes, Gabor; Bánhidy, F.; Ács, N.; Csikós, Julianna.

In: Advances in Therapy, Vol. 22, No. 2, 03.2005, p. 148-154.

Research output: Contribution to journalArticle

Vermes, Gabor ; Bánhidy, F. ; Ács, N. ; Csikós, Julianna. / The effects of Remifemin® on subjective symptoms of menopause. In: Advances in Therapy. 2005 ; Vol. 22, No. 2. pp. 148-154.
@article{e1f42b9582694389b60058c7ba807fef,
title = "The effects of Remifemin{\circledR} on subjective symptoms of menopause",
abstract = "The authors studied the changes in subjective symptoms of menopause in 2016 Hungarian women who had been treated with an isopropanol extract of Cimicifuga racemosa (black cohosh). The inclusion criteria were age (40-65 y). Kupperman index (20), and refusal or contraindication for estrogen therapy. The severity of the symptoms was evaluated at the start of the study and at the end of 4, 8, and 12 weeks of treatment. The average decrease in Kupperman index after 12 weeks of therapy was 17.64 points (P",
keywords = "Black cohosh, Cimicifuga racemosa, Menopause, Phyto-SERM, Remifemin",
author = "Gabor Vermes and F. B{\'a}nhidy and N. {\'A}cs and Julianna Csik{\'o}s",
year = "2005",
month = "3",
language = "English",
volume = "22",
pages = "148--154",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",
number = "2",

}

TY - JOUR

T1 - The effects of Remifemin® on subjective symptoms of menopause

AU - Vermes, Gabor

AU - Bánhidy, F.

AU - Ács, N.

AU - Csikós, Julianna

PY - 2005/3

Y1 - 2005/3

N2 - The authors studied the changes in subjective symptoms of menopause in 2016 Hungarian women who had been treated with an isopropanol extract of Cimicifuga racemosa (black cohosh). The inclusion criteria were age (40-65 y). Kupperman index (20), and refusal or contraindication for estrogen therapy. The severity of the symptoms was evaluated at the start of the study and at the end of 4, 8, and 12 weeks of treatment. The average decrease in Kupperman index after 12 weeks of therapy was 17.64 points (P

AB - The authors studied the changes in subjective symptoms of menopause in 2016 Hungarian women who had been treated with an isopropanol extract of Cimicifuga racemosa (black cohosh). The inclusion criteria were age (40-65 y). Kupperman index (20), and refusal or contraindication for estrogen therapy. The severity of the symptoms was evaluated at the start of the study and at the end of 4, 8, and 12 weeks of treatment. The average decrease in Kupperman index after 12 weeks of therapy was 17.64 points (P

KW - Black cohosh

KW - Cimicifuga racemosa

KW - Menopause

KW - Phyto-SERM

KW - Remifemin

UR - http://www.scopus.com/inward/record.url?scp=21044459867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21044459867&partnerID=8YFLogxK

M3 - Article

C2 - 16020404

AN - SCOPUS:21044459867

VL - 22

SP - 148

EP - 154

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 2

ER -